Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation
暂无分享,去创建一个
P. Montravers | N. Allou | J. Allyn | P. Augustin | L. Massias | C. Welsch
[1] J. Rello,et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] E. Fadel,et al. Incidence of nosocomial pneumonia and risk of recurrence after antimicrobial therapy in critically ill lung and heart–lung transplant patients , 2014, Clinical transplantation.
[3] J. Fraser,et al. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? , 2013, The Journal of antimicrobial chemotherapy.
[4] Kiran Shekar,et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation , 2012, Critical Care.
[5] J. Roberts,et al. Pharmacokinetic issues for antibiotics in the critically ill patient , 2009, Critical care medicine.
[6] K. Rodvold,et al. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections , 2008, Expert opinion on pharmacotherapy.
[7] D. Nicolau,et al. Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections , 2007, Antimicrobial Agents and Chemotherapy.
[8] M. Mangues,et al. Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients. , 1997, Journal of chromatography. B, Biomedical sciences and applications.